AI
CC icon

Analytic Investors’s Chemours CC Stock Holding History

Analytic Investors’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-26,785
Closed -$221K – 602
2016
Q2 		$221K Sell
26,785
-81,621
-75% -$727K ﹤0.01% 569
2016
Q1 		$759K Hold
108,406
– – 0.01% 432
2015
Q4 		$581K Sell
108,406
-94,791
-47% -$606K 0.01% 475
2015
Q3 		$1.31M Buy
+203,197
New +$2.13M 0.02% 333

Other funds holding CC

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Analytic Investors's CC Position: Q3 2016 in Review

Analytic Investors sold out of Chemours (CC) in Q3 2016, closing a stake of 26,785 shares — an estimated $221K sold.

Analytic Investors first reported a position in CC in Q3 2015 and held it in 4 quarters. The position peaked at $1.31M in Q3 2015. 377 funds tracked by Wall St. Rank hold CC as of Q3 2016.

  • Analytic Investors reported no remaining Chemours position as of Q3 2016 after selling out during the quarter.
  • Analytic Investors sold 26,785 Chemours shares in Q3 2016, an estimated $221K.
  • Analytic Investors first reported a position in Chemours in Q3 2015 and held it in 4 quarters.
  • Analytic Investors's Chemours position peaked at $1.31M in Q3 2015.
  • 377 funds tracked by Wall St. Rank held Chemours as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.